Paul Hakendorf
Flinders Medical Centre
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul Hakendorf.
Internal Medicine Journal | 2001
P. J. Roberts-Thomson; M. Jones; Paul Hakendorf; A. A. S. S. Kencana Dharmapatni; Jenny Walker; J. G. Macfarlane; Malcolm D. Smith; M. J. Ahern
Background: Scleroderma is an autoimmune disorder of unknown cause. Previous epidemiological studies have suggested some regional clustering and associations with occupations involving exposure to silica dusts and hydrocarbons.
International Journal of Rheumatic Diseases | 2012
Scott W. Graf; Paul Hakendorf; Susan Lester; Karen Patterson; Jenny Walker; Malcolm D. Smith; M. J. Ahern; P. J. Roberts-Thomson
Aim: To investigate the relationship between scleroderma‐specific autoantibodies and clinical phenotype and survival in South Australian patients with scleroderma.
Internal Medicine Journal | 2011
P Hissaria; S. Lester; Paul Hakendorf; Richard J. Woodman; Karen Patterson; Catherine Hill; M. J. Ahern; Malcolm D. Smith; Jennifer G. Walker; P. J. Roberts-Thomson
Aim: To ascertain the mortality risk and investigate clinical and serological factors influencing survival of patients listed on the South Australian Scleroderma Register (SASR).
International Journal of Rheumatic Diseases | 2013
Ju Ann Tan; P. J. Roberts-Thomson; Peter C. Blumbergs; Paul Hakendorf; Sally Cox; Vidya Limaye
Aim: To describe the epidemiology of biopsy‐proven idiopathic inflammatory myopathies (IIM) in South Australia (SA).
Internal Medicine Journal | 2006
P. J. Roberts-Thomson; Jennifer G. Walker; Tim Yu-Ting Lu; Adrian Esterman; Paul Hakendorf; Malcolm D. Smith; M. J. Ahern
Background: The aim of this study was to determine the incidence, prevalence, survival and selective demographic characteristics of scleroderma occurring in South Australia over the 10‐year period 1993–2002.
Internal Medicine Journal | 2012
Vidya Limaye; Paul Hakendorf; Richard J. Woodman; Peter C. Blumbergs; P. J. Roberts-Thomson
Background: There is a paucity of literature on the patterns and predictors of mortality in idiopathic inflammatory myopathies (IIM).
Arthritis & Rheumatism | 2015
Kevin Patterson; P. J. Roberts-Thomson; S. Lester; Juann Tan; Paul Hakendorf; Maureen Rischmueller; Jane Zochling; Joanne Sahhar; Peter Nash; Janet Roddy; Catherine Hill; Mandana Nikpour; Wendy Stevens; Susanna Proudman; Jennifer G. Walker
To determine the relationships between systemic sclerosis (SSc)–related autoantibodies, as well as their clinical associations, in a well‐characterized Australian patient cohort.
Internal Medicine Journal | 2013
Tuck Y. Yong; Jie Shen Fok; Paul Hakendorf; David I. Ben-Tovim; Campbell H. Thompson; Jordan Yz Li
Discharge against medical advice (DAMA) occurs when an in‐patient chooses to leave the hospital before discharge is recommended by the treating clinicians. The long‐term outcomes of patients who DAMA are not well documented.
Geriatrics & Gerontology International | 2012
Tuck Y. Yong; Su Yin Lau; Jordan Yuanzhi Li; Paul Hakendorf; Campbell H. Thompson
Aim: This study assessed medication use patterns and polypharmacy in patients who were admitted through an acute assessment unit (AAU) and stratified results according to patient age. This study also examined risk factors associated with polypharmacy and consequences of polypharmacy, namely prescription writing errors, drug–drug interaction and geriatric syndrome.
Anz Journal of Surgery | 2004
Matthew D. Ryan; David Wattchow; Margaret Walker; Paul Hakendorf
Background: Acute clinical indicators of complications in colorectal surgery can be readily attained but it is much harder to gather indicators of long‐term outcomes such as small bowel obstruction (SBO). However, with improved in‐hospital data collection and coding such information is becoming available. The aim of the present study was to examine our own hospital database for SBO rates post‐colorectal surgery.